BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36622536)

  • 1. Clinicopathological features and prognosis of primary membranous nephropathy in combination with crescent.
    Pan Y; Liu L; Chen W; Yang H; Zhang J; Wang Y
    Int Urol Nephrol; 2023 Jun; 55(6):1523-1530. PubMed ID: 36622536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological Characteristics and Outcomes of PLA
    Luo J; Yuan Y; Tian J; Zhou Z; Su C; Yang F; Wang G
    Am J Kidney Dis; 2022 Sep; 80(3):364-372. PubMed ID: 35288217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection.
    Wang R; Wu Y; Zheng B; Zhang X; An D; Guo N; Wang J; Guo Y; Tang L
    Sci Rep; 2021 Sep; 11(1):18407. PubMed ID: 34526634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.
    Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I
    Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of M
    Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against M-Type Phospholipase A2 Receptor May Predict Treatment Response and Outcome in Membranous Nephropathy.
    Qu Z; Zhang MF; Cui Z; Wang J; Wang M; Zhang YM; Wang F; Wang X; Meng LQ; Cheng XY; Liu G; Zhao MH
    Am J Nephrol; 2018; 48(6):438-446. PubMed ID: 30472708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membranous nephropathy with crescents: a series of 19 cases.
    Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD
    Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and long-term prognostic features of membranous nephropathy with crescents: a Japanese single-center experience.
    Saito M; Komatsuda A; Sato R; Saito A; Kaga H; Abe F; Sawamura M; Nara M; Togashi M; Okuyama S; Wakui H; Takahashi N
    Clin Exp Nephrol; 2018 Apr; 22(2):365-376. PubMed ID: 28852884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy.
    Guo Y; Wu X; Liu L; Zhang H; Yang L; Chen W
    Ren Fail; 2020 Nov; 42(1):122-130. PubMed ID: 31957527
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
    Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
    Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy - a retrospective cohort study.
    Provatopoulou S; Kalavrizioti D; Stangou M; Kouri MN; Kalliakmani P; Papasotiriou M; Papachristou E; Goumenos DS; Papagianni A
    Rom J Intern Med; 2019 Jun; 57(2):141-150. PubMed ID: 30864406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
    Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features of idiopathic membranous nephropathy combined with IgA nephropathy: a retrospective analysis of 9 cases.
    Hu R; Xing G; Wu H; Zhang Z
    Diagn Pathol; 2016 Sep; 11(1):86. PubMed ID: 27624606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].
    Wang D; Wang F; Ding J; Xiao H; Zhong X; Liu X
    Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):670-5. PubMed ID: 26757967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of serum anti-phospholipase A2 receptor antibody as a biomarker in membranous nephropathy: An experience from a tertiary care center of Eastern India.
    Mukherjee S; Kumar A; Maity P; Sengupta M; Basu K; Chaudhury AR; Bandopadhyay M; Chakraborty BC
    Indian J Pathol Microbiol; 2023; 66(2):269-277. PubMed ID: 37077067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.
    Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L
    Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [C1q or IgA deposition in glomeruli of children with primary membranous nephropathy].
    Xu K; Wang F; Wang ZH; Sun LY; Yao Y; Xiao HJ; Liu XY; Su BG; Zhong XH; Guan N; Zhang HW; Ding J
    Zhonghua Er Ke Za Zhi; 2022 Sep; 60(9):901-907. PubMed ID: 36038299
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study.
    Yin P; Wang J; Liang W; Zhan L; Liu Y; Lin J; Chen X; He Y; Jian H; Xie Z; Tan X; Ye Q; Huang F
    Ren Fail; 2020 Nov; 42(1):675-683. PubMed ID: 32674643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy.
    Stefan G; Stancu S; Zugravu A; Popa O; Zubidat D; Petre N; Mircescu G
    Ren Fail; 2022 Dec; 44(1):258-268. PubMed ID: 35172682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seropositive PLA2R-associated membranous nephropathy but biopsy-negative PLA2R staining.
    Luo J; Zhang W; Su C; Zhou Z; Wang G
    Nephrol Dial Transplant; 2021 Dec; 36(12):2216-2223. PubMed ID: 33236093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.